Robust Learning Approaches

Robust Learning Approaches for Assessing Effects and Effect Heterogeneity of Real World Antipsychotic Treatment Regimes in Elderly Persons with Schizophrenia

5R01MH130213-02

12/2022-10/2027

We will develop statistical approaches to extract scientifically robust and valid causal evidence of the effectiveness and adverse outcomes of antipsychotic drugs used by elderly adults with schizophrenia using large, observational, longitudinal databases. Our proposal has high public health relevance because (1) we focus on adults with illnesses associated with a heavy disease burden for whom drug treatments are a critical and often lifetime treatment component; (2) we assess the extent to which patient race/ethinicity and social contextual factors known to influence health behaviors may moderate outcomes; (3) we expand causal inference methodology to characterize the outcome effects of drug exposure and drug regimens, thus providing valuable information to optimize outcomes of long and complex exposures typical of usual care settings; and (4) we develop generalizable approaches to target parameters of general scientific interest.

Publications

2025

Max Rubinstein, Denis Agniel, Larry Han, Marcela Horvitz-Lennon, and Sharon-Lise Normand. 2025. “Bounding Causal Effects With an Unknown Mixture of Informative and Non-Informative Censoring
Max Rubinstein, Denis Agniel, Larry Han, Marcela Horvitz-Lennon, and Sharon-Lise Normand. 2025. “Bounding Causal Effects With an Unknown Mixture of Informative and Non-Informative Censoring

Presentations

Max Rubinstein presented a poster on "A Sensitivity Analysis Framework for Informative Censoring" at the 2024 ARM Academy Health conference on July 1, 2024 in Baltimore, MD. 

Bella Qian presented and chaired a session in the New England Student Research Symposium on Statistics and Data Science hosted by the Boston Chapter of the ASA on April 20, 2024 at Boston University. 

Bella Qian presented a poster, "Enhancing Causal Inference for Multi-Valued Treatments: A Confounder Balanced Deep Learning Instrumental Variable Approach" at the 2024 Boston Pharmaceutical Symposium on Friday November 1, 2024 in Cambridge, MA.

Marcela Horvitz-Lennon presented research findings at the Seventeenth Workshop on Costs and Assessment in Psychiatry - Mental Health Outcomes, Services, Economics, Policy Research
International Center of Mental Health Policy and Economics (ICMPE) in March 2025 in Venice, Italy. 

 

Study Team